Mechanisms of renal hyporesponsiveness to BNP in heart failure
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F15%3A00062968" target="_blank" >RIV/00159816:_____/15:00062968 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1139/cjpp-2014-0356" target="_blank" >http://dx.doi.org/10.1139/cjpp-2014-0356</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1139/cjpp-2014-0356" target="_blank" >10.1139/cjpp-2014-0356</a>
Alternative languages
Result language
angličtina
Original language name
Mechanisms of renal hyporesponsiveness to BNP in heart failure
Original language description
The B-type natriuretic peptide (BNP), a member of the family of vasoactive peptides, is a potent natriuretic, diuretic, and vasodilatory peptide that contributes to blood pressure and volume homeostasis. These attributes make BNP an ideal drug that couldaid in diuresing a fluid-overloaded patient who had poor or worsening renal function. Despite the potential benefits of BNP, accumulating evidence suggests that simply increasing the amount of circulating BNP does not necessarily increase natriuresis inpatients with heart failure (HF). Moreover, despite high BNP levels, natriuresis falls when HF progresses from a compensated to a decompensated state, suggesting the emergence of renal resistance to BNP. Although likely multifactorial, several mechanisms have been proposed to explain renal hyporesponsiveness in HF, including, but not limited to, decreased renal BNP availability, down-regulation of natriuretic peptide receptors, and altered BNP intracellular signal transduction pathways.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: St. Anne´s University Hospital Brno - International Clinical Research Center (FNUSA-ICRC)</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Canadian Journal of Physiology and Pharmacology
ISSN
0008-4212
e-ISSN
—
Volume of the periodical
93
Issue of the periodical within the volume
6
Country of publishing house
CA - CANADA
Number of pages
5
Pages from-to
399-403
UT code for WoS article
000355237100003
EID of the result in the Scopus database
—